| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $86,402,031 ) (Continued on the next page) |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | F31DK146724 | Skeletal muscle MIRO1 Mediates Insulin Resistance and Muscular Complications in Type 2 Diabetes | 000 | 1 | NIH | 8/10/2026 | $50,114 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | F30AI203126 | Identification and functional characterization of ultra-rare variants in childhood lupus | 000 | 1 | NIH | 8/19/2026 | $38,889 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | R00AG086524 | Investigating TFEB as a critical node to improve proteostatic maintenance and skeletal muscle function with age | 000 | 3 | NIH | 8/24/2026 | $249,000 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | K01DK144648 | The function of injury-specific macrophages in acute kidney injury | 000 | 2 | NIH | 7/3/2026 | $159,386 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | R21AG103782 | Alpha-Ketoglutarate: A Novel Therapeutic Strategy to Improve Neurogliovascular Coupling and Cognitive Aging in Older Adults | 000 | 1 | NIH | 8/31/2026 | $214,500 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | R03DE036378 | Mechanistic insights into cisplatin resistance during secondhand smoke exposure | 000 | 1 | NIH | 9/17/2026 | $286,000 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | R01CA303462 | Targeting Progesterone Resistance for Endometrial Cancer Prevention | 000 | 1 | NIH | 9/10/2026 | $437,142 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | R35GM162254 | Molecular and cellular mechanisms of fluid balance in C. elegans | 000 | 1 | NIH | 9/7/2026 | $288,713 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | R01NS146455 | Evaluating radiographic and clinical injury in myelopathic and non-myelopathic cervical spinal compression | 000 | 1 | NIH | 9/17/2026 | $597,396 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | R01NS143112 | Time-Restricted Feeding as a Therapeutic Intervention Against Acute White Matter Ischemic Injury in Aging | 000 | 1 | NIH | 9/17/2026 | $566,715 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | R34NR022364 | SPIRIT: A Culturally Grounded Supportive Care Intervention for Chickasaw Nation Patients with Cancer | 000 | 1 | NIH | 9/2/2026 | $653,357 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 Research Pkwy Ste 560 | Oklahoma City | OK | 73104-3650 | OKLAHOMA | USA | T7300033 | OKLAHOMA LEND: MCH INTERDISCIPLINARY LEADERSHIP GRANT | 02 | 29 | HRSA | 6/11/2026 | $161,082 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | T7300033 | OKLAHOMA LEND: MCH INTERDISCIPLINARY LEADERSHIP GRANT | 03 | 29 | HRSA | 7/1/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 Research Pkwy Ste 560 | Oklahoma City | OK | 73104-3650 | OKLAHOMA | USA | T7300033 | OKLAHOMA LEND: MCH INTERDISCIPLINARY LEADERSHIP GRANT | 00 | 30 | HRSA | 9/23/2026 | $477,225 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 Research Pkwy Ste 560 | Oklahoma City | OK | 73104-3650 | OKLAHOMA | USA | D8755825 | Dental Faculty Loan Repayment | 00 | 1 | HRSA | 8/25/2026 | $96,760 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 Research Pkwy Ste 560 | Oklahoma City | OK | 73104-3650 | OKLAHOMA | USA | T3256079 | NRSA for Primary Medical Care | 00 | 1 | HRSA | 9/11/2026 | $590,232 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 Research Pkwy Ste 560 | Oklahoma City | OK | 73104-3650 | OKLAHOMA | USA | GE1HS60035 | Oklahoma Stroke Network Initiative | 00 | 1 | HRSA | 9/14/2026 | $4,584,000 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 Research Pkwy Ste 560 | Oklahoma City | OK | 73104-3650 | OKLAHOMA | USA | T1255919 | Grants to States to Support Oral Health Workforce Activities | 00 | 1 | HRSA | 9/8/2026 | $400,000 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | R01HL156856 | A dialogue between neutrophils and monocytes for effective resolution of inflammation following acute myocardial injury | 000 | 6 | NIH | 8/7/2026 | $557,857 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | F30HL176087 | The Role of Lymphatic Endothelial Cell- Expressed Sphingosine-1-Phosphate Receptor 1 on Immune Cell Trafficking and Response to Influenza Virus | 000 | 3 | NIH | 8/25/2026 | $47,191 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | R01DA059480 | Multilevel stress influences on longitudinal trajectories of tobacco use among young adults throughout the US | 000 | 3 | NIH | 5/6/2026 | $386,906 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | U19MD020537 | Improving Cancer Outcomes In Native American Communities (ICON) | 001 | 3 | NIH | 7/21/2026 | $3,480,124 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | R37CA276924 | Vitamin B6 Modulates NK Cell Metabolism in Pancreatic Cancer | 000 | 4 | NIH | 8/6/2026 | $387,341 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | R01AG085398 | Metabolic determinants of reactive astrogliosis and cognitive heterogeneity in aging | 000 | 3 | NIH | 6/5/2026 | $443,080 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | U54CA274329 | Pancreatic Cancer ARTNet Center | 001 | 5 | NIH | 9/7/2026 | $1,266,014 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | R01CA260449 | Exploiting gold nanoparticle as a probe to identify therapeutic targets | 001 | 5 | NIH | 4/16/2026 | $35,496 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA260449 | Exploiting gold nanoparticle as a probe to identify therapeutic targets | 000 | 5 | NIH | 12/4/2025 | $319,463 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | UG1CA233193 | A Lead Academic Participating Site in Oklahoma for the Design and Conduct of NCTN Clinical Trials | 003 | 7 | NIH | 6/8/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | UG1CA233193 | A Lead Academic Participating Site in Oklahoma for the Design and Conduct of NCTN Clinical Trials | 002 | 7 | NIH | 5/27/2026 | $1,290,000 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | F31AG099660 | The Role of Senescence and Endothelial to Mesenchymal Transition in the Aging Cerebral Vasculature | 001 | 1 | NIH | 5/27/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | F31AG099660 | The Role of Senescence and Endothelial to Mesenchymal Transition in the Aging Cerebral Vasculature | 002 | 1 | NIH | 7/29/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | F31AG099660 | The Role of Senescence and Endothelial to Mesenchymal Transition in the Aging Cerebral Vasculature | 000 | 1 | NIH | 5/27/2026 | $38,600 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | R03CA301367 | Evaluating inherited genetic variation and outcome among children andadolescents treated for acute myeloid leukemia | 000 | 1 | NIH | 4/21/2026 | $318,411 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | R01MD021599 | Tailored Mobile Health Technology to Address Native American Chronic Pain | 000 | 1 | NIH | 9/1/2026 | $715,543 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | R01AG088321 | Adipose-brain crosstalk in age-related vascular cognitive impairment: Mechanisms and mediators | 000 | 1 | NIH | 8/26/2026 | $43,626 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | R01AG088321 | Adipose-brain crosstalk in age-related vascular cognitive impairment: Mechanisms and mediators | 000 | 1 | NIH | 8/26/2026 | $350,000 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | R03CA301367 | Evaluating inherited genetic variation and outcome among children andadolescents treated for acute myeloid leukemia | 001 | 1 | NIH | 5/28/2026 | $21,500 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | R01AI198553 | Efficacy of targeting GAPM3 to block acute and chronic Toxoplasma gondii infections | 000 | 1 | NIH | 6/25/2026 | $463,290 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | R35GM164073 | Regulation of Hepatic Drug Transport Proteins: Identifying Novel Drug Interaction Signals | 000 | 1 | NIH | 6/25/2026 | $382,339 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | R01CA315811 | A Novel Intervention to Increase Smoking Quit Attempts and Cessation among Adults Initially Unready to Quit | 000 | 1 | NIH | 7/22/2026 | $606,142 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | U01CA296929 | High-fat diet regulates granulocyte metabolism and function in pancreatic cancer | 000 | 1 | NIH | 8/27/2026 | $525,586 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | R35GM160442 | Dynamics of Fungal Stress Responses in the Host Environment | 000 | 2 | NIH | 6/23/2026 | $393,250 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | U54GM104938 | Oklahoma Shared Clinical and Translational Resources | 001 | 14 | NIH | 7/7/2026 | $3,999,999 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | R01DA065710 | Identifying and Addressing the Impact of Parental Vaping-Related Knowledge and Parenting Behaviors on Adolescents' Nicotine and Cannabis Vaping: A Longitudinal Observational and Experimental Approach | 001 | 1 | NIH | 7/2/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | R01DA065710 | Identifying and Addressing the Impact of Parental Vaping-Related Knowledge and Parenting Behaviors on Adolescents' Nicotine and Cannabis Vaping: A Longitudinal Observational and Experimental Approach | 000 | 1 | NIH | 5/14/2026 | $417,284 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | K01DA063913 | Integrating Peer Mentoring Into Social Media-Based Vaping Cessation Interventions for Young Adults | 000 | 1 | NIH | 5/1/2026 | $200,951 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | F32DK146538 | Developmental Programming of Mitochondrial Function and Pediatric MASLD | 001 | 1 | NIH | 5/5/2026 | $0 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | F32DK146538 | Developmental Programming of Mitochondrial Function and Pediatric MASLD | 000 | 1 | NIH | 5/5/2026 | $79,068 |
| | 2026 | 2026 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY STE 560 | OKLAHOMA CITY | OK | 73104-3650 | OKLAHOMA | USA | F30NS143384 | Determining the Role of Mitochondrial Hydrogen Peroxide in the Regulation of Neuronal Mitochondrial Networks | 002 | 1 | NIH | 4/15/2026 | $576 |
|
